Millennium Management’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.21M Buy
+55,817
New +$1.03M ﹤0.01% 4260
2025
Q2
Sell
-86,574
Closed -$1.39M 6226
2025
Q1
$1.39M Buy
+86,574
New +$1.61M ﹤0.01% 4105
2024
Q4
Sell
-62,353
Closed -$1.09M 6346
2024
Q3
$1.09M Buy
62,353
+23,817
+62% +$406K ﹤0.01% 4198
2024
Q2
$431K Sell
38,536
-2,791
-7% -$26.3K ﹤0.01% 4677
2024
Q1
$360K Buy
+41,327
New +$380K ﹤0.01% 5024
2023
Q4
Sell
-47,754
Closed -$192K 6434
2023
Q3
$192K Buy
47,754
+11,873
+33% +$73.8K ﹤0.01% 5138
2023
Q2
$258K Buy
35,881
+1,555
+5% +$9.93K ﹤0.01% 4988
2023
Q1
$115K Sell
34,326
-10,719
-24% -$32.3K ﹤0.01% 5375
2022
Q4
$125K Sell
45,045
-13,606
-23% -$30.6K ﹤0.01% 5504
2022
Q3
$135K Sell
58,651
-61,685
-51% -$100K ﹤0.01% 5850
2022
Q2
$184K Buy
+120,336
New +$303K ﹤0.01% 5678
2021
Q3
Sell
-17,535
Closed -$288K 7137
2021
Q2
$288K Buy
+17,535
New +$334K ﹤0.01% 5761
2020
Q4
Sell
-18,780
Closed -$221 5500
2020
Q3
$221 Buy
18,780
+17
+0.1% +$183 ﹤0.01% 4022
2020
Q2
$196K Buy
+18,763
New +$169K ﹤0.01% 3851
2018
Q1
Sell
-12,272
Closed -$290K 3986
2017
Q4
$290K Buy
+12,272
New +$290K ﹤0.01% 3371
2017
Q2
Sell
-11,975
Closed -$244K 3766
2017
Q1
$244K Buy
+11,975
New +$163K ﹤0.01% 3131
2016
Q4
Sell
-30,674
Closed -$193K 3637
2016
Q3
$193K Buy
+30,674
New +$156K ﹤0.01% 2994

Other funds holding PLSE

Millennium Management's PLSE Position: Q1 2026 in Review

Millennium Management opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 55,817 shares worth $1.21M. The stake represents ﹤0.01% of the portfolio and ranks #4260 among its holdings. This is a return to the name: Millennium Management previously reported a position in PLSE as recently as Q1 2025.

Millennium Management first reported a position in PLSE in Q3 2016 and has held it in 17 quarters since. The position peaked at $1.39M in Q1 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Millennium Management held 55,817 shares of Pulse Biosciences worth $1.21M as of Q1 2026.
  • Pulse Biosciences was a new Millennium Management position in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4260 holding.
  • Millennium Management first reported a position in Pulse Biosciences in Q3 2016 and has held it in 17 quarters since.
  • Millennium Management's Pulse Biosciences position peaked at $1.39M in Q1 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.